Eyenovia, Inc. (NASDAQ:EYEN), a micro-cap healthcare company currently valued at $63.55 million, announced Wednesday it is changing its corporate name to Hyperion DeFi, Inc. and will begin trading under the new ticker symbol "HYPD" on the Nasdaq Capital Market starting July 3, 2025.
The company, which describes itself as the first publicly-listed U.S. company to build a strategic treasury of HYPE tokens, said the rebranding reflects its cryptocurrency treasury reserve strategy focused on the native token of the Hyperliquid protocol. According to InvestingPro data, the stock has shown significant volatility, with a current price of $12.45 representing just 10% of its 52-week high.
"Our corporate name change to Hyperion DeFi, Inc. reflects our new vision for the company and represents the next important step in the evolution of our cryptocurrency treasury reserve strategy," said Michael Rowe, Chief Executive Officer, in a press release statement.
The company also announced that its co-branded validator "Kinetiq x Hyperion" is now officially live. Hyperion DeFi has begun staking its HYPE holdings to generate yield and prepare for its on-chain engagement strategies.
While pursuing its cryptocurrency strategy, the company continues to develop its Optejet User Filled Device (UFD), designed to work with topical ophthalmic liquids including artificial tears and lens rewetting products. InvestingPro analysts project 65.92% revenue growth for fiscal year 2025, though the company’s financial health score remains weak at 1.25. Get access to 12+ additional ProTips and comprehensive analysis with an InvestingPro subscription.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.